✦ LIBER ✦

Evaluating rapid virological response reduces ribavirin and peginterferon alfa-2B treatment costs for chronic hepatitis C in the United Kingdom

✍ Scribed by J.B. Wong; W.M. Rosenberg; M.P. Manns; G.L. Davis; J.G. McHutchison; J.K. Albrecht

Book ID: 117372102
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 319 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80003-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is peginterferon alfa-2B plus ribavirin

Is peginterferon alfa-2B plus ribavirin cost-effective for treating chronic hepatitis C in the United Kingdom?

✍ J.B. Wong; W.M. Rosenberg; M.P. Manns; J.G. McHutchison; G.L. Davis; J.K. Albrec 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Early virologic response to treatment wi

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Economic and clinical effects of evaluat

Economic and clinical effects of evaluating rapid viral response to peginterferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C

✍ John B Wong; Gary L Davis; John G McHutchison; Michael P Manns; Janice K Albrech 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGI

PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON (ALFA-2B) WITH RIBAVIRIN COMPARED WITH PEGINTERFERON (ALFA-2A) WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C

✍ VV Omelyanovsky; MV Avksentieva; I Krysanov; O Ivakhnenko 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Cost-effectiveness of interferon alfa 2b

Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C

✍ W. Ray Kim; John J. Poterucha 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

In their paper in the November issue of HEPATOLOGY, Younossi et al. 1 may have overestimated the cost effectiveness of interferon-ribavirin treatment. This mainly stems from their failure to take into account the fact that patients who achieve sustained response are not homogenous with respect to th

Early virologic response and IL28B polym

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

✍ Thomas-Matthias Scherzer; Harald Hofer; Albert Friedrich Staettermayer; Karoline 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 801 KB